Semi-Annual Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7302029

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Semi-annual statement of income
Statement of income
Net sales
28,617,000,000 JPY
151,000,000 JPY
3,640,000,000 JPY
32,371,000,000 JPY
32,409,000,000 JPY
-38,000,000 JPY
3,162,000,000 JPY
31,675,000,000 JPY
28,404,000,000 JPY
31,648,000,000 JPY
-27,000,000 JPY
108,000,000 JPY
Cost of sales
16,463,000,000 JPY
16,461,000,000 JPY
Ordinary profit (loss)
3,312,000,000 JPY
3,096,000,000 JPY
Gross profit (loss)
15,907,000,000 JPY
15,186,000,000 JPY
Selling, general and administrative expenses
12,561,000,000 JPY
12,130,000,000 JPY
Extraordinary income
JPY
2,314,000,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
3,312,000,000 JPY
5,410,000,000 JPY
Operating profit (loss)
3,825,000,000 JPY
-4,000,000 JPY
177,000,000 JPY
3,345,000,000 JPY
3,998,000,000 JPY
-652,000,000 JPY
44,000,000 JPY
3,641,000,000 JPY
3,658,000,000 JPY
3,055,000,000 JPY
-585,000,000 JPY
-61,000,000 JPY
Non-operating income
204,000,000 JPY
224,000,000 JPY
Income taxes - current
602,000,000 JPY
1,424,000,000 JPY
Non-operating income
Interest income
1,000,000 JPY
2,000,000 JPY
Dividend income
148,000,000 JPY
187,000,000 JPY
Income taxes - deferred
150,000,000 JPY
-143,000,000 JPY
Non-operating expenses
238,000,000 JPY
183,000,000 JPY
Income taxes
752,000,000 JPY
1,280,000,000 JPY
Profit (loss)
2,560,000,000 JPY
4,129,000,000 JPY
Non-operating expenses
Interest expenses
22,000,000 JPY
21,000,000 JPY
Extraordinary income

Talk to a Data Expert

Have a question? We'll get back to you promptly.